This new program is specifically aimed at helping patients with Type 2 diabetes, who take medications to control their blood sugar levels.
Are you a start-up in Maryland, DC or Virginia seeking feedback on your biohealth business idea, pitch deck, or commercialization plan? business/commercialization plan, pitch deck, or idea?
Schedule your feedback session with BHI EIRs on one of the following dates:
- 2/27
- 3/20
- 5/22
(30 minute blocks of time beginning at 9:00 in the morning. If the morning slots are filled, more time will be allotted beginning at 1 p.m.)
Pre-registration is required; sign up here (“EIR resource”at BHI). For questions/more information, contact BHI.
- How do you obtain coverage and payment for your technology?
- Is the process different for medical devices from diagnostics or therapeutics?
- Can digital apps be reimbursed?
- How do I work with bundled payments?
- What is the process for securing reimbursement codes? Do I need different strategies based upon the point of care?
- How much do I need to budget for a reimbursement strategy? When do I need one?
- How to I talk to investors about my reimbursement strategy?
Learn the answers to these questions and more through the November 14th PathFinder Innovation Program. (There is no charge to attend in person or by videoconference, however, pre-registration by NOON, 11/13 is required).
- 8:15 a.m. Networking and Coffee
- 8:30 a.m. – Issues Overview (in person/by videoconference)
- Speakers: Brian Abraham, Founder, Lara Reimbursement Advisory
- Luis Gutierrez, Entrepreneur-in-Residence, NHLBI and BioHealth Innovation
- 9:30 a.m. – 1:1 Office Hours (in person/by videoconference)*
This program is cosponsored by BioHealth Innovation, Launch Workplaces, TEDCO and Montgomery County. It is open to anyone in the BioHealth Capital Region.
To register/For more information, email: BHI@BioHealthInnovation. (In person 1:1 scheduling: www.tinyurl.com/BHIappointments.)
*Attendance at Overview in person/by videoconference required to participate in 1:1 sessions.
TaiRx, Inc and BioHealth Innovation, Inc. (BHI) announced today the formation of TaiRx US, a new joint venture. The mission of the new company is to develop therapeutics and precision medicine diagnostics focused on the Nodal protein, a critical mediator of aggressive cancer progression and treatment resistance.
TaiRx, Inc and BHI have formed TaiRx US, which will be based in Rockville (Montgomery County), Maryland, to develop and commercialize a unique monoclonal antibody with the potential to reverse drug resistance in various tumor types. The company is also working to develop a companion diagnostic to accurately identify those patients who can best benefit from the therapy.
TEDCO makes market research databases available to Maryland entrepreneurs (excluding consultants) at various locations including the Germantown Innovation Center. For a description of these databases, click here. To schedule an appointment to use the databases in Germantown, register here.
BioHealth Innovation, Inc. (BHI) provides international companies the perfect starting point to create or locate US-based subsidiaries by offering a soft landing to companies seeking to grow their US business and access BHI, federal and state resources. For more information, click here.
To foster development, production and marketing of the next generation of medical devices designed to meet growing children’s unique needs, the Food and Drug Administration (FDA) awarded $5 million to the National Capital Consortium for Pediatric Device Innovation (NCC-PDI), led by Children’s National Health System and University of Maryland, College Park. New Consortium members include BioHealth Innovation, Inc., a Maryland-based innovation intermediary that supports the transformation of research projects into new business opportunities, and MedTech Innovator, a California-based virtual startup accelerator that matches health care industry leaders with early-stage and emerging growth medtech companies for mentorship and support. NCC-PDI’s affiliated members include industry leaders such as Smithwise, Epidarex, and Cadence.
Consulting Assistance
BHI’s team of EIRs, analysts, and SBIR consultants can help you improve your SBIR and other non-dilutive funding applications for biohealth related projects. Services include review and editing to increase the competitiveness of the grant applications, as well as more in-depth grant writing support. Depending upon the type of award sought, company resources, status of the technology, etc., the company’s obligation may be nothing until an award is granted or a nominal fee up front and the remainder only after the award has been granted.
For more information contact Jon Nelson at jnelson@biohealthinnovation.org.